License AgreementLicense Agreement • September 15th, 2014 • England
Contract Type FiledSeptember 15th, 2014 JurisdictionThis LICENSE AGREEMENT (the “Agreement”) is made as of September 15, 2014 (the “Effective Date”) by and between Gilead Sciences Limited an Irish corporation having its principal place of business at IDA Business & Technology Park, Carigtohill, Co. Cork, Ireland
PURCHASE ORDER TERMS AND CONDITIONSGilead Sciences • August 25th, 2015
Contract Type FiledAugust 25th, 2015IF THE PARTIES HAVE ENTERED INTO A MASTER SERVICE AGREEMENT OR OTHER CONTRACT (“EXISTING AGREEMENT”) THAT COVERS THE GOODS OR SERVICES THAT ARE THE SUBJECT OF THIS PURCHASE ORDER AND SUCH EXISTING AGREEMENT IS STILL IN EFFECT SUCH EXISTING AGREEMENT SHALL GOVERN AND SHALL BE DEEMED SET OUT IN FULL IN THIS PURCHASE ORDER TO THE EXCLUSION OF THE TERMS AND CONDITIONS SET OUT BELOW. IF THERE IS NO SUCH EXISTING AGREEMENT THEN THE TERMS AND CONDITIONS SET OUT BELOW SHALL APPLY TO THIS PURCHASE ORDER.
AMENDED AND RESTATED LICENSE AGREEMENTAmended And • October 4th, 2017 • England
Contract Type FiledOctober 4th, 2017 JurisdictionThis AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is made as of (the “Amended and Restated Effective Date”) by and between Gilead Sciences, Inc. a Delaware corporation having its principal place of business at 333 Lakeside Drive, Foster City, California 94404, USA (“Gilead”), and , a company registered under the laws of India, and having a registered office at
ContractMay 28th, 2024
FiledMay 28th, 2024Gilead Sciences - Support to Patient Organisations 01/01/2023 - 31/12/2023 Country Name of Patient Organization Description of support Local currency Amount Nature of Support Activity Russia Autonomous non-profit organization "Rehabilitation Center of Natalya Ustyuzhanina for Social and Psycological Assistance to Chemical Addicts "Generation" Donation agreement to support project in relation to HIV- positive children and their families RUB 998475,00 Financial Russia Autonomous non-profit organization "Rehabilitation Center of Natalya Ustyuzhanina for Social and Psycological Assistance to Chemical Addicts "Generation" Generation Tyumen T2 (Unmet Need Round 2) - 01JAN2023-28FEB2023 RUB 3420674,97 Financial Russia Autonomous non-profit organization "Rehabilitation Center of Natalya Ustyuzhanina for Social and Psycological Assistance to Chemical Addicts "Generation" Generation Tyumen T3 (Unmet Need #2) RUB 3815924,72 Financial Russia Autonomous non-profit organization "Rehabilitation
Amended and Restated License Agreement (TEMPLATE)Amended and Restated License Agreement (Template) • June 13th, 2012 • England
Contract Type FiledJune 13th, 2012 JurisdictionThis AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is made as of July , 2011 (the “Effective Date”) by and between Gilead Sciences, Inc. a Delaware corporation having its principal place of business at 333 Lakeside Drive, Foster City, California 94404, USA (“Gilead”), and a company registered under the laws of India, and having a registered office at
AMENDED AND RESTATED LICENSE AGREEMENTAmended And • November 20th, 2017 • England
Contract Type FiledNovember 20th, 2017 Jurisdiction, 2017 (the “Amended and Restated Effective Date”) by and between Gilead Sciences Ireland UC, an Irish unlimited liability company having its principal place of business at IDA Business & Technology Park, Carigtohill, Co. Cork, Ireland (“Gilead”), and [Name of Licensee], a [type of company], and having a registered office at [address of Licensee] (“Licensee”). Gilead and Licensee may each be referred to herein as a “Party” or collectively as the “Parties.”
RDV License AgreementRDV License Agreement • May 9th, 2022 • New York
Contract Type FiledMay 9th, 2022 JurisdictionThis RDV LICENSE AGREEMENT (the “Agreement”) is made as of [Date] (the “Effective Date”) by and between Gilead Sciences, Inc. a Delaware corporation having its principal place of business at 333 Lakeside Drive, Foster City, California 94404, USA (“Gilead”), and [ ], a corporation of [ _] and having a registered office at [ ] (“Licensee”). Gilead and Licensee may each be referred to herein as a “Party” or collectively as the “Parties.”
License AgreementLicense Agreement • June 13th, 2012
Contract Type FiledJune 13th, 2012WHEREAS, Gilead wishes to facilitate access to its antiviral agents to patients in the developing world to help satisfy unmet medical needs;